Sign inJoin waitlistJoin the waitlist

Camila Manrique

Professor of Medicine · University of Missouri-Columbia School of Medicine

Credentials: · · ·

History

Endocrinology, Diabetes, and Metabolism
University of Missouri School of Medicine
2004–2006
Internal Medicine
University of Missouri School of Medicine
2001–2004
Universidad Nacional de Colombia. Facultad de Medicina
1997–2001

Research

Endothelial Glycocalyx
Comprehensive physiology · 2022 · 151 citations
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
Cardiovascular Diabetology · 2018 · 145 citations
Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities
Hepatology · 2020 · Last of 9 authors · 106 citations

AA
Annayya Aroor
13 papers
Adam Whaley-Connell
8 papers
FA
Francisco Amador
7 papers · 5 as a resident
JS
James Sowers
7 papers
Guido Gonzalez
5 papers
Andrew Wheeler
3 papers
Ayman Gaballah
3 papers
David Gozal
2 papers
EC
Edgar Cortes
2 papers · 1 as a resident
Irl Hirsch
2 papers
Rama Ganga
2 papers
Ravi Nistala
2 papers

Grants

Arterial Destiffening Effects of SGLT2 Inhibition in Veterans with Obesity
Department of Veterans Affairs · I01
PI · Harry s. Truman Memorial Va Hospital
2025–2029
SGLT2 Inhibition as a Therapeutic Strategy to Reverse Arterial Stiffening in Aging
National Institute on Aging · R01
Contact PI · $1.8M · University of Missouri-Columbia
2024–2029
Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes
Department of Veterans Affairs · I01
Contact PI · Harry s. Truman Memorial Va Hospital
2022–2028
Estrogen Receptor Alpha Signaling in Endothelial Cells Exacerbates Arterial Stiffening via Upregulation of ENaC in Insulin Resistant Females
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.7M · University of Missouri-Columbia
2019–2025